Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer

Completed · Phase 3

Conditions studied: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which combination chemotherapy regimen is more effective for urinary tract cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of cisplatin plus gemcitabine with or without paclitaxel in treating patients who have stage IV urinary tract cancer.

Key facts

Study ID

NCT00022191

Run by

European Organisation for Research and Treatment of Cancer - EORTC

People needed

608

Starts

2001-05-01

Last updated by the study team

2013-06-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Arizona Cancer Center at University of Arizona Health Sciences Center — Tucson, Arizona, United States
• Veterans Affairs Medical Center - Little Rock (McClellan) — Little Rock, Arkansas, United States
• City of Hope Comprehensive Cancer Center — Duarte, California, United States
• USC/Norris Comprehensive Cancer Center and Hospital — Los Angeles, California, United States
• Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
• Veterans Affairs Outpatient Clinic - Martinez — Martinez, California, United States
• Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center — Orange, California, United States
• University of California Davis Cancer Center — Sacramento, California, United States
• University of Colorado Cancer Center at University of Colorado Health Sciences Center — Aurora, Colorado, United States
• Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital) — Hines, Illinois, United States
• Cardinal Bernardin Cancer Center at Loyola University Medical Center — Maywood, Illinois, United States
• Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center — Kansas City, Kansas, United States
• Veterans Affairs Medical Center - Lexington — Lexington, Kentucky, United States
• Markey Cancer Center at University of Kentucky Chandler Medical Center — Lexington, Kentucky, United States
• Tulane University School of Medicine — New Orleans, Louisiana, United States
• Veterans Affairs Medical Center - New Orleans — New Orleans, Louisiana, United States
• Louisiana State University Health Sciences Center - Shreveport — Shreveport, Louisiana, United States
• Veterans Affairs Medical Center - Shreveport — Shreveport, Louisiana, United States
• Cancer Research Center at Boston Medical Center — Boston, Massachusetts, United States
• Veterans Affairs Medical Center - Ann Arbor — Ann Arbor, Michigan, United States
• University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
• Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
• Josephine Ford Cancer Center at Henry Ford Hospital — Detroit, Michigan, United States
• Providence Cancer Institute at Providence Hospital — Southfield, Michigan, United States
• Veterans Affairs Medical Center - Tucson — Tucson, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.